Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +14.31% | +20.42% | +4.67% |
05-14 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | MiNK Therapeutics, Inc. announced that it has received $5.8 million in funding | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.67% | 38.87M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+50.07% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- Transcript : MiNK Therapeutics, Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-18-2023 11